Skip to main content

Month: May 2024

First Guaranty Bancshares, Inc Announces CEO Retirement

HAMMOND, La., May 29, 2024 (GLOBE NEWSWIRE) — First Guaranty Bancshares, Inc. announced today that Alton Lewis will retire from his role as President and Chief Executive Officer of First Guaranty Bancshares, Inc. and First Guaranty Bank in May, 2024, after a dynamic and successful tenure. Mr. Lewis has been a part of the First Guaranty family for over three decades. He began his service as Board member in 1988 and became President and CEO in 2009. Under his leadership, First Guaranty grew from a $931 million institution to what it is today, $3.6 billion. Mr. Lewis was also instrumental in coordinating the IPO of the First Guaranty stock, FGBI, in 2015. Additional notable achievements are that he successfully led his team through the COVID pandemic, maintaining consistent operations of all bank functions. These achievements, plus...

Continue reading

Mayfair Gold Supplements Disclosure Contained in Management Information Circular

MATHESON, Ontario, May 29, 2024 (GLOBE NEWSWIRE) — Mayfair Gold Corp. (“Mayfair” or the “Company”) (TSX-V: MFG; OTCQB: MFGCF) provides the following disclosure to supplement its management information circular dated May 6, 2024 (the “Circular”) for the annual general and special meeting of shareholders to be held on June 5, 2024 (the “Meeting”). Shareholders are encouraged to read the Circular, which is available on www.sedarplus.ca, as well as the Investor Resources section of the Company’s website at https://mayfairgold.ca/investor-resources/, in conjunction with this news release. Amendments to Employment Agreements In March 2020, Mayfair entered into an agreement to acquire the Fenn-Gib gold project in the Timmins region of Ontario. In August 2020, the Board of Directors of Mayfair (the “Board”), comprised of Henry Heeney and...

Continue reading

Kneat Announces Results of Voting at Annual General Meeting

LIMERICK, Ireland, May 29, 2024 (GLOBE NEWSWIRE) — kneat.com, inc. (TSX: KSI) (“Kneat” or the “Company”) a leader in digitizing and automating validation and quality processes, announced results from its Annual General Meeting of Shareholders (the “2024 AGM”), which took place today. All director nominees were elected to the board of directors (the “Kneat Board”) and KPMG LLP was appointed as auditors, as further described in the related Management Information Circular dated April 24, 2024 (the “Circular”). The detailed results of voting at the 2024 AGM are set out below: 1. Election of Directors Shareholders voted to elect all six directors nominated to the Kneat Board.Name of Nominee Number of Votes Cast Votes “For” Votes “For” %Ian Ainsworth 40,123,881 40,123,560 100Kevin...

Continue reading

Descartes Announces Fiscal 2025 First Quarter Financial Results

Record Revenues and Income from Operations WATERLOO, Ontario and ATLANTA, May 29, 2024 (GLOBE NEWSWIRE) —  The Descartes Systems Group Inc. (TSX:DSG) (Nasdaq:DSGX) announced its financial results for its fiscal 2025 first quarter (Q1FY25). All financial results referenced are in United States (US) currency and, unless otherwise indicated, are determined in accordance with US Generally Accepted Accounting Principles (GAAP). “Global trade is complex and constantly evolving. Supply chains and logistics operations continue to be impacted by a myriad of factors, including military conflicts, disruptions to trade routes, government sanctions, and material changes to taxes and tariffs,” said Edward J. Ryan, Descartes’ CEO. “Our technology solutions are designed to help shippers, carriers and logistics services...

Continue reading

Abcourt Announces its Results for the Third Quarter ended March 31, 2024

ROUYN-NORANDA, Quebec, May 29, 2024 (GLOBE NEWSWIRE) — Abcourt Mines Inc. (“Abcourt” or the “Corporation”) (TSX Venture: ABI) (OTCQB : ABMBF) announces its results for the three months ended March 31, 2024. All monetary values in this press release are expressed in Canadian dollars, unless otherwise indicated. The financial statements and management report are available on SEDAR+. Highlights for the Quarter ended March 31, 2024Exploration work totaling $1,765,615 for the quarter, exploration expenses incurred mainly on the Sleeping Giant property for the underground drilling campaign for an amount of approximately $1,709,229. Following the work carried out during the quarter, the Corporation confirmed the existence of a second gold mineralized zone to the east of the Flordin deposit towards the Cartwright deposit in the Lebel-sur-Quévillon...

Continue reading

Petrus Resources Declares Monthly Dividend for June 2024

CALGARY, Alberta, May 29, 2024 (GLOBE NEWSWIRE) — Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to confirm that its Board of Directors has declared a monthly dividend in the amount of $0.01 per share payable June 28, 2024, to shareholders of record on June 17, 2024. The dividend is designated as an eligible dividend for Canadian income tax purposes. ABOUT PETRUSPetrus is a public Canadian oil and gas company focused on property exploitation, strategic acquisitions and risk-managed exploration in Alberta. FOR FURTHER INFORMATION PLEASE CONTACT:Ken Gray President and Chief Executive Officer T: 403-930-0889 E: kgray@petrusresources.com

Continue reading

Reviva Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

CUPERTINO, Calif., May 29, 2024 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 1,898,734 shares of the Company’s common stock and warrants to purchase up to 1,898,734 shares of common stock at a combined offering price of $1.58 per share of common stock and accompanying warrant priced at-the-market under the Nasdaq rules. The warrants have an exercise price of $1.455 per share, are immediately exercisable and will expire five years following the date of issuance. H.C. Wainwright &...

Continue reading

Voxtur Announces Financial Results for the Three Months Ended March 31, 2024

TORONTO and TAMPA, Fla., May 29, 2024 (GLOBE NEWSWIRE) — Voxtur Analytics Corp. (TSXV: VXTR; OTCQB: VXTRF) (“Voxtur” or the “Company”), a North American technology company creating a more transparent and accessible real estate lending ecosystem, today announced its financial results for the three months ended March 31, 2024. The Unaudited Condensed Interim Consolidated Financial Statements and the related Management’s Discussion and Analysis (“MD&A”) for the three months ended March 31, 2024, are available at www.sedarplus.ca and at www.voxtur.com. “We are pleased to report a strong start to 2024, showcasing our commitment to strategic financial management and innovation. Efforts on reducing the Company’s debt has been our primary focus, while also shifting resources towards...

Continue reading

Sow Good Signs Lease for New Distribution Facility in Dallas, Texas

New 324,000 sq. ft. Facility Expected to Significantly Increase In-House Production Capacity Dallas Facility Expected to House All Incoming Additional Freeze Driers IRVING, Texas, May 29, 2024 (GLOBE NEWSWIRE) — Sow Good, Inc. (Nasdaq: SOWG) (“Sow Good” or “the Company”), a trailblazer in the freeze-dried candy and treat industry, proudly announces a major expansion with a long-term lease for a new 324,000 sq. ft. production facility in Dallas, Texas. This strategic move is set to dramatically boost the Company’s production capacity, accelerating Sow Good’s ability to meet the soaring demand for its innovative freeze-dried treats. The state-of-the-art Dallas facility dedicates approximately 306,500 sq. ft. to production, packaging, and distribution, while reserving 17,400 sq. ft. for office space. This new hub will streamline...

Continue reading

X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia

Webcast to include interim hematological results from at least 15 trial participants and feature experts in the treatment of chronic neutropenia BOSTON, May 29, 2024 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that it will host a virtual investor event on Thursday, June 27, 2024 at 8:00 am ET. To register for the event, click here. The event will focus on new interim results from an ongoing Phase 2 clinical trial exploring the use of mavorixafor as a once-daily oral treatment in patients with chronic neutropenia (CN). The data to be presented will include hematological results from at least 15 study participants treated with either mavorixafor monotherapy or mavorixafor in combination with stable doses of injectable...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.